Zaid A. Soomro

Clinical Research Scientist at MD Anderson Cancer Center | Clinical Informaticist at UTHealth School of Biomedical Informatics

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases


Journal article


O. Alhalabi, Zaid Soomro, R. Sun, E. Hasanov, A. Albittar, D. Tripathy, V. Valero, N. Ibrahim
NPJ breast cancer, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Alhalabi, O., Soomro, Z., Sun, R., Hasanov, E., Albittar, A., Tripathy, D., … Ibrahim, N. (2021). Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases. NPJ Breast Cancer.


Chicago/Turabian   Click to copy
Alhalabi, O., Zaid Soomro, R. Sun, E. Hasanov, A. Albittar, D. Tripathy, V. Valero, and N. Ibrahim. “Outcomes of Changing Systemic Therapy in Patients with Relapsed Breast Cancer and 1 to 3 Brain Metastases.” NPJ breast cancer (2021).


MLA   Click to copy
Alhalabi, O., et al. “Outcomes of Changing Systemic Therapy in Patients with Relapsed Breast Cancer and 1 to 3 Brain Metastases.” NPJ Breast Cancer, 2021.


BibTeX   Click to copy

@article{o2021a,
  title = {Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases},
  year = {2021},
  journal = {NPJ breast cancer},
  author = {Alhalabi, O. and Soomro, Zaid and Sun, R. and Hasanov, E. and Albittar, A. and Tripathy, D. and Valero, V. and Ibrahim, N.}
}